https://novapharmanews.com/eu/news/first-glp-1-gene-therapy-clinical-trial-europe 2026-05-21T10:13:16.265Z NovaPharmaNews en-GB 2026-05-21T08:07:20.460Z First GLP-1 Gene Therapy Clinical Trial Approved in Europe GLP-1, gene therapy https://novapharmanews.com/uploads/articles/first-glp-1-gene-therapy-clinical-trial-europe.webp First GLP-1 Gene Therapy Clinical Trial Approved in Europe https://novapharmanews.com/us/news/biomarin-swot-analysis-rare-disease-biotech 2026-05-21T16:12:43.023Z NovaPharmaNews en-US 2026-05-21T08:07:20.460Z BioMarin's SWOT Analysis: Competitive Headwinds in Rare Disease Biotech rare disease https://novapharmanews.com/uploads/articles/biomarin-swot-analysis-rare-disease-biotech.webp BioMarin's SWOT Analysis: Competitive Headwinds in Rare Disease Biotech https://novapharmanews.com/us/news/new-fda-guidance-ends-nicotine-pouches 2026-05-21T15:47:00.948Z NovaPharmaNews en-US 2026-05-21T08:07:20.460Z New FDA Guidance on ENDS and Nicotine Pouch Products https://novapharmanews.com/uploads/articles/new-fda-guidance-ends-nicotine-pouches.webp New FDA Guidance on ENDS and Nicotine Pouch Products https://novapharmanews.com/us/news/fda-lifting-restrictions-compounded-peptides 2026-05-21T16:38:34.477Z NovaPharmaNews en-US 2026-05-21T08:06:59.876Z FDA to Consider Lifting Restrictions on Compounded Peptides https://novapharmanews.com/uploads/articles/fda-lifting-restrictions-compounded-peptides.webp FDA to Consider Lifting Restrictions on Compounded Peptides https://novapharmanews.com/us/news/fda-alert-pulmonology-drug-approvals 2026-05-21T16:38:35.621Z NovaPharmaNews en-US 2026-05-21T08:06:59.876Z FDA Alert: Key Updates on Pulmonology Drug Approvals https://novapharmanews.com/uploads/articles/fda-alert-pulmonology-drug-approvals.webp FDA Alert: Key Updates on Pulmonology Drug Approvals https://novapharmanews.com/us/news/fda-expands-market-access-ends-products 2026-05-21T16:12:53.165Z NovaPharmaNews en-US 2026-05-21T08:06:59.876Z FDA Expands Market Access for ENDS Products: What You Need to Know https://novapharmanews.com/uploads/articles/fda-expands-market-access-ends-products.webp FDA Expands Market Access for ENDS Products: What You Need to Know https://novapharmanews.com/us/news/2026-pharma-ma-breakout-year 2026-05-21T16:13:08.569Z NovaPharmaNews en-US 2026-05-21T08:06:59.876Z Will 2026 Be Pharma’s M&A Breakout Year? Market Analysis https://novapharmanews.com/uploads/articles/2026-pharma-ma-breakout-year.webp Will 2026 Be Pharma’s M&A Breakout Year? Market Analysis https://novapharmanews.com/us/news/migraine-drugmaker-reverse-merger-market-analysis 2026-05-21T16:23:04.025Z NovaPharmaNews en-US 2026-05-21T08:06:59.876Z Migraine Drugmaker's Reverse Merger: Market Insights migraine https://novapharmanews.com/uploads/articles/migraine-drugmaker-reverse-merger-market-analysis.webp Migraine Drugmaker's Reverse Merger: Market Insights https://novapharmanews.com/us/news/takeda-novartis-layoffs-pharma-impact 2026-05-21T16:28:58.138Z NovaPharmaNews en-US 2026-05-21T08:06:59.876Z Takeda and Novartis Layoffs: Implications for Pharma Industry https://novapharmanews.com/uploads/articles/takeda-novartis-layoffs-pharma-impact.webp Takeda and Novartis Layoffs: Implications for Pharma Industry https://novapharmanews.com/us/news/regeneron-pharma-stock-institutional-buying-insights 2026-05-21T15:12:53.572Z NovaPharmaNews en-US 2026-05-21T08:06:59.876Z Regeneron Pharma Stock Surges: Fresh Institutional Buying Insights https://novapharmanews.com/uploads/articles/regeneron-pharma-stock-institutional-buying-insights.webp Regeneron Pharma Stock Surges: Fresh Institutional Buying Insights https://novapharmanews.com/eu/news/fda-approves-aldosterone-synthase-inhibitor-hypertension 2026-05-21T16:13:06.579Z NovaPharmaNews en-GB 2026-05-21T08:06:52.523Z FDA Approves First-in-Class Aldosterone Synthase Inhibitor for Uncontrolled Hypertension aldosterone synthase inhibitor, uncontrolled hypertension https://novapharmanews.com/uploads/articles/fda-approves-aldosterone-synthase-inhibitor-hypertension.webp FDA Approves First-in-Class Aldosterone Synthase Inhibitor for Uncontrolled Hypertension https://novapharmanews.com/apac/news/dishman-carbogen-amcis-shanghai-nmpa-gmp-audit 2026-05-21T16:13:05.521Z NovaPharmaNews en-AU 2026-05-21T08:06:52.523Z Dishman Carbogen Amcis Shanghai Site Achieves NMPA GMP Compliance https://novapharmanews.com/uploads/articles/dishman-carbogen-amcis-shanghai-nmpa-gmp-audit.webp Dishman Carbogen Amcis Shanghai Site Achieves NMPA GMP Compliance https://novapharmanews.com/apac/news/kissei-pharmaceutical-halts-tavneos-use-amid-deaths 2026-05-21T15:23:45.099Z NovaPharmaNews en-AU 2026-05-21T08:06:52.523Z Kissei Pharmaceutical Halts Tavneos Use Amid Deaths Tavneos https://novapharmanews.com/uploads/articles/kissei-pharmaceutical-halts-tavneos-use-amid-deaths.webp Kissei Pharmaceutical Halts Tavneos Use Amid Deaths https://novapharmanews.com/apac/news/novartis-pluvicto-stronger-psa-responses-prostate-cancer 2026-05-21T16:46:04.728Z NovaPharmaNews en-AU 2026-05-21T08:06:52.523Z Novartis Strengthens Prostate Cancer Treatment with Pluvicto Pluvicto, oncology, prostate cancer https://novapharmanews.com/uploads/articles/novartis-pluvicto-stronger-psa-responses-prostate-cancer.webp Novartis Strengthens Prostate Cancer Treatment with Pluvicto https://novapharmanews.com/apac/news/regulatory-round-up-drug-approvals-18-may-2026 2026-05-21T16:38:46.914Z NovaPharmaNews en-AU 2026-05-21T08:06:52.523Z Regulatory Round-Up: Drug Approvals on 18 May 2026 https://novapharmanews.com/uploads/articles/regulatory-round-up-drug-approvals-18-may-2026.webp Regulatory Round-Up: Drug Approvals on 18 May 2026 https://novapharmanews.com/apac/news/zte-partners-china-national-clinical-research-center 2026-05-21T16:38:57.237Z NovaPharmaNews en-AU 2026-05-21T08:06:52.523Z ZTE Partners with China's National Clinical Research Center for Clinical Trials https://novapharmanews.com/uploads/articles/zte-partners-china-national-clinical-research-center.webp ZTE Partners with China's National Clinical Research Center for Clinical Trials https://novapharmanews.com/eu/news/florian-lordick-esmo-president-2026-elections-open 2026-05-21T16:48:49.500Z NovaPharmaNews en-GB 2026-05-21T08:06:52.523Z Florian Lordick Elected 2026 ESMO President: Implications for Global Oncology oncology https://novapharmanews.com/uploads/articles/florian-lordick-esmo-president-2026-elections-open.webp Florian Lordick Elected 2026 ESMO President: Implications for Global Oncology https://novapharmanews.com/eu/news/february-batch-novel-medicines-ema-chmp-approval 2026-05-21T16:12:59.172Z NovaPharmaNews en-GB 2026-05-21T08:06:52.523Z February Batch of Novel Medicines Recommended for Approval by EMA/CHMP https://novapharmanews.com/uploads/articles/february-batch-novel-medicines-ema-chmp-approval.webp February Batch of Novel Medicines Recommended for Approval by EMA/CHMP https://novapharmanews.com/us/news/fierce-biotech-week-2026-recap 2026-05-21T16:13:13.477Z NovaPharmaNews en-US 2026-05-20T13:36:09.234Z Fierce Biotech Week 2026: Key Insights and Highlights Fierce, Week https://novapharmanews.com/uploads/articles/fierce-biotech-week-2026-recap.webp Fierce Biotech Week 2026: Key Insights and Highlights https://novapharmanews.com/eu/news/isct-2026-annual-recap 2026-05-21T16:34:03.097Z NovaPharmaNews en-GB 2026-05-20T13:36:09.234Z ISCT 2026 Annual: Key Highlights and Insights https://novapharmanews.com/uploads/articles/isct-2026-annual-recap.webp ISCT 2026 Annual: Key Highlights and Insights https://novapharmanews.com/us/news/oct-east-coast-2026-recap 2026-05-21T16:12:45.037Z NovaPharmaNews en-US 2026-05-20T13:36:09.234Z OCT East Coast 2026: Key Insights and Highlights Coast https://novapharmanews.com/uploads/articles/oct-east-coast-2026-recap.webp OCT East Coast 2026: Key Insights and Highlights https://novapharmanews.com/us/news/thma-cpe-circle-2026-recap 2026-05-21T16:30:47.722Z NovaPharmaNews en-US 2026-05-20T13:36:09.234Z THMA CPE Circle 2026: Key Insights and Highlights Circle https://novapharmanews.com/uploads/articles/thma-cpe-circle-2026-recap.webp THMA CPE Circle 2026: Key Insights and Highlights https://novapharmanews.com/eu/news/global-pharmacovigilance-reporting-comparative-analysis 2026-05-21T16:34:04.235Z NovaPharmaNews en-GB 2026-05-20T05:03:01.071Z Global Pharmacovigilance Reporting: A Comparative Analysis https://novapharmanews.com/uploads/articles/global-pharmacovigilance-reporting-comparative-analysis.webp Global Pharmacovigilance Reporting: A Comparative Analysis https://novapharmanews.com/us/news/sellas-nears-key-aml-data-dual-trials 2026-05-21T11:12:39.872Z NovaPharmaNews en-US 2026-05-20T05:03:01.071Z SELLAS Nears Key AML Data: Insights for Investors and BD Teams acute myeloid leukemia https://novapharmanews.com/uploads/articles/sellas-nears-key-aml-data-dual-trials.webp SELLAS Nears Key AML Data: Insights for Investors and BD Teams https://novapharmanews.com/us/news/fda-bayesian-methodology-drug-development 2026-05-21T16:12:45.639Z NovaPharmaNews en-US 2026-05-20T05:03:01.071Z FDA's Bayesian Methodology: A Game Changer for Drug Development https://novapharmanews.com/uploads/articles/fda-bayesian-methodology-drug-development.webp FDA's Bayesian Methodology: A Game Changer for Drug Development https://novapharmanews.com/eu/news/cma-deal-eu-medicine-supply-chains-analysis 2026-05-21T16:38:57.933Z NovaPharmaNews en-GB 2026-05-20T05:02:52.209Z CMA Deal Strengthens EU Medicine Supply Chains https://novapharmanews.com/uploads/articles/cma-deal-eu-medicine-supply-chains.webp CMA Deal Strengthens EU Medicine Supply Chains https://novapharmanews.com/apac/news/asia-pacific-regulatory-updates-tga-guidance 2026-05-21T15:23:44.425Z NovaPharmaNews en-AU 2026-05-20T05:02:52.209Z Asia-Pacific Regulatory Updates: TGA Guidance on Compounded Medicines https://novapharmanews.com/uploads/articles/asia-pacific-regulatory-updates-tga-guidance.webp Asia-Pacific Regulatory Updates: TGA Guidance on Compounded Medicines https://novapharmanews.com/us/news/layoff-tracker-takeda-novartis-restructuring 2026-05-21T16:39:02.776Z NovaPharmaNews en-US 2026-05-20T05:02:29.102Z Layoff Tracker: Takeda and Novartis Restructuring Impact https://novapharmanews.com/uploads/articles/layoff-tracker-takeda-novartis-restructuring.webp Layoff Tracker: Takeda and Novartis Restructuring Impact https://novapharmanews.com/apac/news/risen-pharma-phase-2-trial-rp902-alzheimers 2026-05-21T16:30:46.605Z NovaPharmaNews en-AU 2026-05-20T05:02:29.102Z Risen Pharma Initiates Phase 2 Trial for RP902 in Alzheimer's RP902, Alzheimer's disease, Mild Cognitive Impairment, Alzheimer’s Disease https://novapharmanews.com/uploads/articles/risen-pharma-phase-2-trial-rp902-alzheimers.webp Risen Pharma Initiates Phase 2 Trial for RP902 in Alzheimer's https://novapharmanews.com/us/news/fda-approves-atezolizumab-ctdna-mrd-positive-mibc 2026-05-21T08:26:22.497Z NovaPharmaNews en-US 2026-05-20T05:02:29.102Z FDA Approves Atezolizumab for ctDNA MRD-Positive MIBC atezolizumab, oncology, MIBC https://novapharmanews.com/uploads/articles/fda-approves-atezolizumab-ctdna-mrd-positive-mibc.webp FDA Approves Atezolizumab for ctDNA MRD-Positive MIBC https://novapharmanews.com/us/news/top-10-biopharma-ma-deals-2025 2026-05-21T11:21:38.451Z NovaPharmaNews en-US 2026-05-20T05:02:29.102Z Top 10 Biopharma M&A Deals of 2025: Market Analysis https://novapharmanews.com/uploads/articles/top-10-biopharma-ma-deals-2025.webp Top 10 Biopharma M&A Deals of 2025: Market Analysis https://novapharmanews.com/eu/news/europes-drug-innovation-edge-risk-dutch-industry-group 2026-05-21T11:12:41.613Z NovaPharmaNews en-GB 2026-05-20T05:02:29.102Z Europe's Drug Innovation Edge at Risk: Insights from Dutch Industry Group https://novapharmanews.com/uploads/articles/europes-drug-innovation-edge-risk-dutch-industry-group.webp Europe's Drug Innovation Edge at Risk: Insights from Dutch Industry Group https://novapharmanews.com/apac/news/shanghai-fosun-pharmaceutical-fda-trial-nod 2026-05-21T11:15:13.860Z NovaPharmaNews en-AU 2026-05-20T05:02:29.102Z Shanghai Fosun Pharmaceutical Stock Surges After FDA Trial Nod https://novapharmanews.com/uploads/articles/shanghai-fosun-pharmaceutical-fda-trial-nod.webp Shanghai Fosun Pharmaceutical Stock Surges After FDA Trial Nod https://novapharmanews.com/eu/news/future-european-medicine-clinical-research 2026-05-21T16:36:28.334Z NovaPharmaNews en-GB 2026-05-20T05:02:29.102Z The Future of European Medicine: The Role of Clinical Research https://novapharmanews.com/uploads/articles/future-european-medicine-clinical-research.webp The Future of European Medicine: The Role of Clinical Research https://novapharmanews.com/eu/news/x4-pharmaceuticals-ema-chmp-mavorixafor-approval 2026-05-21T16:13:18.604Z NovaPharmaNews en-GB 2026-05-20T05:02:29.102Z X4 Pharmaceuticals Gains EMA CHMP Support for Mavorixafor Approval Mavorixafor, WHIM Syndrome https://novapharmanews.com/uploads/articles/x4-pharmaceuticals-ema-chmp-mavorixafor-approval.webp X4 Pharmaceuticals Gains EMA CHMP Support for Mavorixafor Approval